Search filters

List of works by Yehuda Patt

A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.

scientific article published in August 2005

A Randomized, Phase II Trial of Standard Triweekly Compared with Dose-Dense Biweekly Capecitabine Plus Oxaliplatin Plus Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer: XELOX-A-DVS (Dense Versus Standard) ⬇️

scientific article published on May 23, 2012

A phase I study of imexon plus gemcitabine as first-line therapy for advanced pancreatic cancer

scientific article

A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma

scientific article published on 27 May 2008

Association between hypothyroidism and hepatocellular carcinoma: a case-control study in the United States

scientific article published on May 2009

Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results

scientific article published on 01 August 2007

Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study

scientific article published on October 2008

Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma

scientific article published on June 2017

Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer

scientific article published in May 2003

Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: risk and prognosis prediction

scientific article published on 15 June 2013

INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial

scientific article published on 11 August 2017

Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma

scientific article published on 02 July 2013

Novel systemic therapy options for hepatocellular carcinoma

scientific article published on March 2004

OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer.

scientific article

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

scientific article

Phase II Trial Using a Combination of Oxaliplatin, Capecitabine, and Celecoxib with Concurrent Radiation for Newly Diagnosed Resectable Rectal Cancer

scientific article published on 20 November 2017

Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20.

scientific article

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma

scientific article

Recombinant human interleukin-11 improves thrombocytopenia in patients with cirrhosis

scientific article

Rising prevalence of hepatitis C virus infection among patients recently diagnosed with hepatocellular carcinoma in the United States

scientific article published in September 2002

Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus

scientific article

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study

scientific article published on 23 February 2007

Thalidomide in the treatment of patients with hepatocellular carcinoma: a phase II trial

scientific article published in February 2005

The association of family history of liver cancer with hepatocellular carcinoma: a case-control study in the United States

scientific article

Treatment of hepatocellular carcinoma in the community: disparities in standard therapy

scientific article published on March 2015

Paulina is supported by:

About Paulina

Help